Approval · Notice of Compliance 3238 · 1998
FLOMAX: Notice of Compliance 3238
Issued June 1, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3238
- Date
- June 1, 1998
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective adrenergic receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLOMAX | 02238123 | Cancelled Post Market |
Medicinal ingredients
- TAMSULOSIN HYDROCHLORIDE 0.4 MG per CAP